臨床研究等提出・公開システム

A clinical study of non-invasive diagnostic criteria for detrusor underactivity

A clinical study of non-invasive diagnostic criteria for detrusor underactivity

Yoshida Masaki

Sakura Jyuji Hospital

11-1-1, Miyukikibe, Kumamoto Shi Minami Ku, Kumamoto Ken

masa.yoshida@sakurajyuji.jp

Tsukamoto Ken

Taiho Pharmaceutical Company

1-27 Kandanishikicho, Chiyoda-ku, Tokyo To

+81-6-7176-5731

k-tsukamoto@taiho.co.jp

Not Recruiting

Mar. 13, 2023

Observational

diagnostic purpose

-Written consent was given for participation in the study.
- Age at the time of informed consent is 18 years or older.
- Willingness to adhere to the visit schedule and procedures specified in this study, and compliance is possible
-Of the three voiding symptoms of UAB's syndrome as defined by ICS (hypovolemia, delayed voiding, abdominal pressure voiding), having any two or more symptoms for at least 12 weeks

-Researchers and others judged the participation of this study to be inappropriate.

Both

UAB syndrome

Diagnostic predictive value based on noninvasive diagnostic criteria for DU.(%)

-PFS parameters (urine collection period)
-PFS parameters (voiding phase)
-Uroflowmetry parameters
-Ultrasonographic PVR
-BVE(%)
-International Prostate Symptom Score
-Major lower urinary tract symptom-score (CLSS).
-ICIQ-UAB Score
-Adverse events
-BCI (men) and PIP1 (women) tabulation
Summarized statistics of BCI (men) and PIP1 (women).
-Urinary micro RNA analysis (only in collaborating laboratories where micro RNA analysis is feasible)

+81-96-378-1111

Mar. 13, 2023

No

none